Ruth Cheng, PhD
Chief Innovation and Strategy Officer & Vice President of Corporate Development
“I’ve always been fascinated by the possibilities of science—by the ‘what ifs’ of the future and of all that science can enable. At ATCC, we are enabling scientific discovery at a rapid pace through the application of our digital and physical content. We value ingenuity and tackle the world's toughest challenges in global health. Our work brings credibility and real-world value to scientific exploration, and knowing that it ultimately translates into better lives for countless people provides an endless source of inspiration.”
Role at ATCC
In her role as chief innovation and strategy officer and vice president of corporate development, Ruth leads corporate strategy, strategic partnerships, and internal and external innovation efforts. Ruth is a member of the executive leadership team and is transforming ATCC to lead at the forefront of science.
Before joining ATCC, she served as vice president of Global Strategy at AgNovos Healthcare, where she led multiple departments and strategic initiatives to expand the company’s portfolio and market access, including regulatory and clinical research. She was director of Innovation and Strategy for the Advanced Surgical Devices Division of Smith+Nephew, where she oversaw strategic planning and was responsible for portfolio expansion through product development and corporate venturing. And earlier in her career, Ruth worked at Boston Scientific where she was manager of Corporate Research and Research Fellow.
Ruth received her bachelor’s in biological sciences from Cornell University and her master’s and doctorate in biomedical engineering from the University of Michigan. She holds executive certificates in Strategy & Innovation from MIT Sloan and Private Equity & Venture Capital from Harvard Business School. She has authored numerous scientific publications and more than a dozen patents. She also is an invited lecturer at congresses and universities on medical technology innovation.